Used as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of selective enzyme inhibitors and central nervous system agents. Its structure supports enhanced metabolic stability and membrane permeability, making it valuable in medicinal chemistry for optimizing drug candidates. Commonly employed in the preparation of bioactive molecules where halogenated amines improve binding affinity and pharmacokinetic profiles.